The Nigeria Centre for Disease Control (NCDC), on Thursday,
announced a new case management guideline for the treatment and discharge of
COVID-19 pandemic patients.
Dr. Chikwe Ihekweazu, Director-General of NCDC, made this
known at the Presidential Task Force on COVID-19 (PTF) media briefing in Abuja.
Ihekweazu said that the third version of the guidelines was
released following the emergence of new science about the duration of
infectivity of individual patients.
The director-general said that the guidelines were for
symptomatic and asymptomatic patients.
According to him, symptomatic patients will now be
discharged at least ten days after symptom onset and at least three days
without symptoms.
“For asymptomatic patients, they can be discharged 14 days
after the first PCR positive test.
“We no longer have to wait for a negative test to discharge,
with the confidence that you can go home, and you are no longer infectious or
putting family or friends at risk.
“If your symptoms last longer, we will wait while managing
it,” Ihekweazu said.
Ihekweazu said that physicians were hesitant about the new
guidelines, assuring them that the new guidelines were effective.
The NCDC chief said the centre had also removed the use of
antivirals and Chloroquine and hydroxychloroquine from its treatment
guidelines.
He said the antivirals would now be used only on trials
setting and casually because its safety was uncertain
Click to signup for FREE news updates, latest information and hottest gists everyday
Advertise on NigerianEye.com to reach thousands of our daily users
No comments
Post a Comment
Kindly drop a comment below.
(Comments are moderated. Clean comments will be approved immediately)
Advert Enquires - Reach out to us at NigerianEye@gmail.com